1-11 of 11
Benjamin M. Scirica
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT

Ildiko Lingvay, John Deanfield, Steven E. Kahn, Peter E. Weeke, Hermann Toplak, Benjamin M. Scirica, Lars Rydén, Naveen Rathor, Jorge Plutzky, Cristobal Morales, A. Michael Lincoff, Michael Lehrke, Ole Kleist Jeppesen, Grzegorz Gajos, Helen M. Colhoun, Bertrand Cariou, Donna Ryan, SELECT Trial Investigators
Journal: Diabetes Care
Diabetes Care 2024;47(8):1360–1369
https://doi.org/10.2337/dc24-0764
Published: 22 June 2024
View article titled, Semaglutide and Cardiovascular Outcomes by Baseline HbA<sub>1c</sub> and Change in HbA<sub>1c</sub> in People With Overweight or Obesity but Without Diabetes in SELECT
Open the PDF for Semaglutide and Cardiovascular Outcomes by Baseline HbA<sub>1c</sub> and Change in HbA<sub>1c</sub> in People With Overweight or Obesity but Without Diabetes in SELECT in another window
Journal Articles

Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes

Filipe A. Moura, David D. Berg, Andrea Bellavia, Jamie P. Dwyer, Ofri Mosenzon, Benjamin M. Scirica, Stephen D. Wiviott, Deepak L. Bhatt, Itamar Raz, Mark W. Feinberg, Eugene Braunwald, David A. Morrow, Marc S. Sabatine
Journal: Diabetes Care
Diabetes Care 2023;46(10):1807–1815
https://doi.org/10.2337/dc23-0492
Published: 09 August 2023
View article titled, Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes
Open the PDF for Risk Assessment of Kidney Disease Progression and Efficacy of SGLT2 Inhibition in Patients With Type 2 Diabetes in another window
Journal Articles

A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes

David D. Berg, Stephen D. Wiviott, Benjamin M. Scirica, Thomas A. Zelniker, Erica L. Goodrich, Petr Jarolim, Ofri Mosenzon, Avivit Cahn, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Per Johanson, Anna Maria Langkilde, Itamar Raz, Eugene Braunwald, Marc S. Sabatine, David A. Morrow
Journal: Diabetes Care
Diabetes Care 2021;44(11):2573–2581
https://doi.org/10.2337/dc21-1170
Published: 17 September 2021
View article titled, A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes
Open the PDF for A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes in another window
Journal Articles

NT-proBNP: Can We Better Utilize Biomarkers in Patients With Diabetes?

Matthew A. Cavender, Benjamin M. Scirica
Journal: Diabetes Care
Diabetes Care 2020;43(12):2904–2905
https://doi.org/10.2337/dci20-0047
Published: 12 November 2020
View article titled, NT-proBNP: Can We Better Utilize Biomarkers in Patients With Diabetes?
Open the PDF for NT-proBNP: Can We Better Utilize Biomarkers in Patients With Diabetes? in another window
Journal Articles

Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease

Brian A. Bergmark, Deepak L. Bhatt, Eugene Braunwald, David A. Morrow, Ph. Gabriel Steg, Yared Gurmu, Avivit Cahn, Ofri Mosenzon, Itamar Raz, Erin Bohula, Benjamin M. Scirica
Journal: Diabetes Care
Diabetes Care 2018;41(3):577–585
https://doi.org/10.2337/dc17-1736
Published: 01 December 2017
View article titled, Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease
Open the PDF for Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease in another window
Includes: Supplementary data
Journal Articles

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial

Ofri Mosenzon, Gil Leibowitz, Deepak L. Bhatt, Avivit Cahn, Boaz Hirshberg, Cheryl Wei, KyungAh Im, Aliza Rozenberg, Ilan Yanuv, Christina Stahre, Kausik K. Ray, Nayyar Iqbal, Eugene Braunwald, Benjamin M. Scirica, Itamar Raz
Journal: Diabetes Care
Diabetes Care 2017;40(1):69–76
https://doi.org/10.2337/dc16-0621
Published: 17 October 2016
View article titled, Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial
Open the PDF for Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial

Avivit Cahn, Itamar Raz, Ofri Mosenzon, Gil Leibowitz, Ilan Yanuv, Aliza Rozenberg, Nayyar Iqbal, Boaz Hirshberg, Mikaela Sjostrand, Christina Stahre, KyungAh Im, Estella Kanevsky, Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald
Journal: Diabetes Care
Diabetes Care 2016;39(8):1329–1337
https://doi.org/10.2337/dc15-2763
Published: 23 May 2016
View article titled, Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial
Open the PDF for Predisposing Factors for Any and Major Hypoglycemia With Saxagliptin Versus Placebo and Overall: Analysis From the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial

Ofri Mosenzon, Cheryl Wei, Jaime Davidson, Benjamin M. Scirica, Ilan Yanuv, Aliza Rozenberg, Boaz Hirshberg, Avivit Cahn, Christina Stahre, Krzysztof Strojek, Deepak L. Bhatt, Itamar Raz
Journal: Diabetes Care
Diabetes Care 2015;38(11):2142–2150
https://doi.org/10.2337/dc15-1068
Published: 10 September 2015
View article titled, Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial
Open the PDF for Incidence of Fractures in Patients With Type 2 Diabetes in the SAVOR-TIMI 53 Trial in another window
Journal Articles

Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial

Lawrence A. Leiter, Hwee Teoh, Eugene Braunwald, Ofri Mosenzon, Avivit Cahn, K.M. Prasanna Kumar, Alena Smahelova, Boaz Hirshberg, Christina Stahre, Robert Frederich, Francois Bonnici, Benjamin M. Scirica, Deepak L. Bhatt, Itamar Raz, for the SAVOR-TIMI 53 Steering Committee and Investigators
Journal: Diabetes Care
Diabetes Care 2015;38(6):1145–1153
https://doi.org/10.2337/dc14-2868
Published: 10 March 2015
View article titled, Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial
Open the PDF for Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial

Jacob A. Udell, Deepak L. Bhatt, Eugene Braunwald, Matthew A. Cavender, Ofri Mosenzon, Ph. Gabriel Steg, Jaime A. Davidson, Jose C. Nicolau, Ramon Corbalan, Boaz Hirshberg, Robert Frederich, KyungAh Im, Amarachi A. Umez-Eronini, Ping He, Darren K. McGuire, Lawrence A. Leiter, Itamar Raz, Benjamin M. Scirica
Journal: Diabetes Care
Diabetes Care 2015;38(4):696–705
https://doi.org/10.2337/dc14-1850
Published: 31 December 2014
View article titled, Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial
Open the PDF for Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial in another window
Includes: Supplementary data
Journal Articles

Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin

Itamar Raz, Deepak L. Bhatt, Boaz Hirshberg, Ofri Mosenzon, Benjamin M. Scirica, Amarachi Umez-Eronini, KyungAh Im, Christina Stahre, Alona Buskila, Nayyar Iqbal, Norton Greenberger, Markus M. Lerch
Journal: Diabetes Care
Diabetes Care 2014;37(9):2435–2441
https://doi.org/10.2337/dc13-2546
Published: 07 August 2014
View article titled, Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin
Open the PDF for Incidence of Pancreatitis and Pancreatic Cancer in a Randomized Controlled Multicenter Trial (SAVOR-TIMI 53) of the Dipeptidyl Peptidase-4 Inhibitor Saxagliptin in another window
Includes: Supplementary data